Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jan 22, 2025
Open Peer Review Period: Feb 4, 2025 - Apr 1, 2025
Date Accepted: Oct 17, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

A Multiple Technology–Based Physical Activity Intervention for Latina Adolescents: Results From the Chicas Fuertes Randomized Controlled Trial

Carson JR, Greenstadt E, Olivera B, Dunsiger S, Zive M, Higgins M, Godino J, Marcus B, Meyer D, Larsen B

A Multiple Technology–Based Physical Activity Intervention for Latina Adolescents: Results From the Chicas Fuertes Randomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e71623

DOI: 10.2196/71623

PMID: 41380028

PMCID: 12697919

Randomized controlled trial of a multiple technology-based physical activity intervention for Latina adolescents: Results from the Chicas Fuertes Randomized Controlled Trial

  • Jacob R Carson; 
  • Emily Greenstadt; 
  • Brittany Olivera; 
  • Shira Dunsiger; 
  • Michelle Zive; 
  • Michael Higgins; 
  • Job Godino; 
  • Bess Marcus; 
  • Dawn Meyer; 
  • Britta Larsen

ABSTRACT

Background:

Latina adolescents report low levels of moderate-vigorous physical activity (MVPA) and high lifetime risk of lifestyle-related diseases. There is a lack of MVPA interventions targeted at this demographic despite documented health disparities. Given their high rates of using mobile technology, interventions delivered through mobile devices may be effective for this population.

Objective:

The current paper examines efficacy of the Chicas Fuertes intervention in increasing MVPA across six months in Latina adolescents.

Methods:

Participants were Latina adolescents (ages 13-18) in San Diego County who reported being underactive (<150 minutes/week of MVPA). All participants received a wearable fitness tracker (Fitbit Inspire HR); half were randomly assigned to also receive the multimedia intervention. Intervention components included a personally tailored website, personalized texting based on Fitbit data, and social media. The primary outcome was change in minutes of weekly MVPA from baseline to six months (6m), measured by ActiGraph accelerometers and the 7-Day Physical Activity Recall Interview. Changes in daily steps using Fitbit devices were also examined to test intervention efficacy.

Results:

Participants (N=160) were 15.3 years old on average, and mostly second generation in the U.S. For ActiGraph-measured MVPA, participants in the Intervention group (N=83) increased from a median of 0 min/week at baseline (IQR 26) to 64 min/week at 6m (IQR 28) compared to Control participants, who showed increases from a median of 0 at baseline (IQR 24) to 41 min/week at 6m (IQR 21) (p<0.05). Self-reported MVPA increased in the Intervention group from a median of 119 min/week at baseline (IQR 122.5) to 147 min/week at 6m (IQR 85) compared to Control participants, who showed increases from a median of 120 (IQR 186.25) at baseline to 124 min/week at 6m (IQR 69) (p<0.05). Steps also increased in both groups, with the Intervention group showing significantly greater increases (p<0.05).

Conclusions:

This intervention was successful in using a tailored technology-based strategy to increase MVPA in Latina adolescents and provides a promising approach for addressing a key health behavior. Given the scalable technology used, future studies should focus on broad scale dissemination to address health disparities. Clinical Trial: ClinicalTrials.gov NCT04190225 . Registered on November 20, 2019.


 Citation

Please cite as:

Carson JR, Greenstadt E, Olivera B, Dunsiger S, Zive M, Higgins M, Godino J, Marcus B, Meyer D, Larsen B

A Multiple Technology–Based Physical Activity Intervention for Latina Adolescents: Results From the Chicas Fuertes Randomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e71623

DOI: 10.2196/71623

PMID: 41380028

PMCID: 12697919

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.